An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
Wesseling J, Tinterri C, Sapino A, Zanconati F, Lutke-Holzik M, Nguyen B, Deck KB, Querzoli P, Perin T, Giardina C, Seitz G, Guinebretière JM, Barone J, Dekker L, de Snoo F, Stork-Sloots L, Roepman P, Watanabe T, Cusumano P.
Wesseling J, et al. Among authors: giardina c.
Virchows Arch. 2016 Sep;469(3):297-304. doi: 10.1007/s00428-016-1979-9. Epub 2016 Jul 4.
Virchows Arch. 2016.
PMID: 27377889